 |
3rd Thursday Community Engagement Education Series - Session 2
Creating and Nurturing Community Advisory Boards
Feb. 18, 2021, 12:00 – 1:00 p.m.
The BU CTSI CE Program Monthly Education Series will provide education on community-engaged research approaches and promote networking among BU colleagues who are actively engaging communities in the research process.
|
Join us and our guest panelists, Astraea Augsberger and Kimberly Nelson, as they share their experiences with Community Advisory Boards |
Assistant Professor
Boston University School of Social Work
Dr. Augsberger is an expert on youth engagement strategies and has been a consultant to the U.S. Department of Health & Human Services on engaging youth in federal priorities. Her research has examined advisory boards in multiple practice settings, including municipal government, child welfare, and healthcare.
|
Assistant Professor
Community Health Sciences
Dr. Nelson focuses on community and population-level health implications while conducting individual-level behavioral research. Dr. Nelson's research concentrates on psychological and structural factors associated with the transmission or acquisition of HIV/STIs among sexual and racial/ethnic minority adolescents and adults.
|
The KL2 program is a mentored career development program for BU's most promising junior faculty translational researchers. This program is committed to increasing the diversity of the research workforce and strongly encourages applications from underrepresented, racial, and ethnic groups (UREGs). Read More
|
Presented at 12 p.m. by: William G. Adams, MD, Kimberly Ann Dukes, PhD, & Heather Hsu, MD, MPH. This 2nd presentation focuses on the "Use of Large Data Sets to Facilitate Research with Underrepresented Groups", which is built upon earlier presentations on research regulatory considerations related to vulnerable subjects. Read More
|
An interactive training program that uses case studies developed and vetted with other Clinical & Translational Science Institutes around the country. This is a great opportunity to interact with and learn from colleagues in other disciplines. A certificate will be supplied to include in your training grant applications. Read More
|
We are delighted to announce that the BU CTSI will support two post-Doctoral fellows as part of the CTSI training program in regenerative medicine. This program is committed to increasing the diversity of the research workforce and strongly encourages applications from underrepresented, racial, and ethnic groups (UREGs). Read More.
|
|
|
|
|
The NIH’s Point-of-Care Technology Research Network (POCTRN) drives the development of point-of-care technologies through collaborative efforts that merge scientific and technological capabilities with clinical need. The goal of the Point Of Care Technology Research Network is to develop technologies with clinical applications using a network model that enhances complementary strengths and builds multidisciplinary partnerships. Expressions of Interest are due March 1, 2021
|
|
|
|
This RFA is focused on supporting collaborative teams of researchers to contribute healthy, single-cell reference data from pediatric tissue samples to the Human Cell Atlas project. This RFA is intended to support established teams as well as new collaborations, and welcomes proposals that will make significant contributions toward single-cell reference data for the community of patients, clinicians, and researchers engaged in pediatric research.
|
|
|
|
|
|
Notice of Intent to Publish Research Opportunity Announcements (OTA-21-015) for the Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Initiative
The solicited research will improve understanding of and develop strategies to prevent and treat post-acute manifestations of SARS-CoV-2 infection across the lifespan.
National Institutes of Health (NIH)
|
|
|
|
Four Potential COVID-19 Therapeutics Enter Phase 2/3 Testing in NIH ACTIV-2 Trial
If an investigational agent shows promise by demonstrating safety and reducing COVD-19 symptoms through 28 days following administration, the ACTIV-2 trial is designed to expand seamlessly from a Phase 2 to Phase 3 study to gather additional critical data. Read More
|
|
|
|
|
NIH Experts Discuss SARS-CoV-2
Viral Variants.
Variants can carry several different mutations, but changes in the spike protein of the virus, used to enter cells and infect them, are especially concerning. Changes to this protein may cause a vaccine to be less effective against a particular variant. Read More
|
|
|
|
|
NIH Calls for Greater Inclusion of Pregnant and Lactating People in COVID-19 Vaccine Research
Longstanding obstacles to include pregnant and lactating people in clinical research have led to this population now deciding whether or not to receive a SARS-CoV-2 vaccine without the benefit of scientific evidence. Read More
|
|
|
|
|
Cancer Researchers Bring Tools, Experience to COVID-19 Studies
Since the pandemic began, cancer researchers have also been contributing their expertise and resources to scientific investigations of the coronavirus. Their findings have been broad in scope, ranging from insights into how the virus enters cells to the identification of potential therapies. Read More
|
|
|
|
|
Coronavirus Vaccines and People with Cancer: A Q&A with Dr. Steven Pergam
We all want to get the vaccines to the people who are at the most risk for severe COVID-19 complications, and the data show that cancer patients are at high risk. Making highly efficacious vaccines available to those populations is going to be important to saving lives. Read More
|
|
|
|
|
RCCN Workshop: Inclusion of Older Adults in Clinical Research
Feb. 23, 2021, 1 - 4:45 p.m.
This RCCN Virtual Workshop will include sessions on aspects of including older adults in clinical research including the Current Situation, Barriers - Real and Perceived, Making the Case, and Best Practices Reaching for Out to Colleagues. More Details Here
|
|
|
|
|
Register Now for Virtual Rare Disease Day at NIH 2021
Mar. 1, 2021, 10:30 a.m - 5:30 p.m.
Each year, NIH hosts this event to raise awareness about rare diseases, the people they affect and research collaborations underway to address scientific challenges and to advance new treatments. The virtual event is free and open to the public.
|
|
|
|
|
Integrating Inflammation and Coagulation in COVID-19
Mar. 04, 2021, 12 p.m.
Speaker Yogen Kanthi is a cardiologist and clinical vascular medicine specialist. He is interested in developing a deeper understanding of how innate immune circuits and communicating with coagulation and the vessel wall to license or restrict thrombosis. More Details Here
|
|
|
|
|
|
Accelerating Discoveries Towards Better Health
|
bu.edu/ctsi | ncats.nih.gov
|
|
|
|
|
|
|
